REPLIGEN CORPORATION FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Nov 4, 2013
  • No warning letters matched by name
Inspections 4 0 OAI
Recalls 1 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

REPLIGEN CORPORATION has 1 FDA recall, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "REPLIGEN CORPORATION" is on file.

What these totals cover: FDA records filed under the name "REPLIGEN CORPORATION".

Latest recall
Z-1024-2026 · Class II · Dec 10, 2025
Latest inspection
Nov 4, 2013 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections4Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing REPLIGEN CORPORATION as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check REPLIGEN CORPORATION yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

1 recall record on Dec 10, 2025.

NumberClassProductDate
Z-1024-2026Class IIMAVERICK¿ Measurement Module Spectrometer PN 820-01367 (originally part of a kit PN 820-01519)…Dec 10, 2025

Recent FDA inspections

4 inspections from Mar 26, 2009 to Nov 4, 2013.

DateSiteProductClassificationFEI
Nov 4, 2013Irving, TXDevicesNo Action Indicated (NAI)1625657
Aug 7, 2013Irving, TXDevicesNo Action Indicated (NAI)1625657
Feb 29, 2012Waltham, MADrugsNo Action Indicated (NAI)3009352682
Mar 26, 2009Irving, TXDevicesNo Action Indicated (NAI)1625657
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1625657Irving, TX3Nov 4, 2013
FEI 3009352682Waltham, MA1Feb 29, 2012

REPLIGEN CORPORATION and the FDA: common questions

Has REPLIGEN CORPORATION received an FDA warning letter?

No FDA warning letter addressed to the name "REPLIGEN CORPORATION" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has REPLIGEN CORPORATION received an FDA Form 483?

FDA has not published a Form 483 for "REPLIGEN CORPORATION" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect REPLIGEN CORPORATION?

The most recent FDA inspection on file ended Nov 4, 2013 at Irving, TX and was classified NAI. FDA has 4 inspections of REPLIGEN CORPORATION on file.

Has REPLIGEN CORPORATION had an FDA recall?

Yes. REPLIGEN CORPORATION has 1 FDA recall on record. The most recent started Dec 10, 2025.

Need more than this page shows? Ask about REPLIGEN CORPORATION in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.